Dr. Gregory Gerber — Unlawful Prescribing and Kickbacks
Federal Court Enters Judgment Against Physician for Unlawful Opioid Prescribing
Source: U.S. Department of Justice
TL;DR: Federal Court Enters Judgment Against Physician for Unlawful Opioid Prescribing This case resulted in a Court Judgment resolution and demonstrates the impact of whistleblower protections in recovering funds from fraud.
Summary
A federal court entered a judgment against Gregory Gerber, MD, including a permanent prohibition on prescribing controlled substances and a monetary judgment, in a civil case alleging violations of the Controlled Substances Act and the False Claims Act. DOJ alleged Gerber wrote opioid and other controlled-substance prescriptions without a legitimate medical basis, and also alleged he received kickback payments from a drug manufacturer connected to prescribing Subsys (fentanyl).
Our Take
Provider prescribing cases usually turn on consistency: repeated clinical shortcuts, repeated departures from standards, and repeated financial linkages that distort decision-making. The strongest insider materials often include prescribing analytics, patient files showing the same template rationale across many patients, and communications about manufacturer relationships or "expectations" tied to a product. If you've seen similar dynamics, the key is documenting the workflow and incentives that made the prescribing pattern predictable—not arguing about any single chart.
Read the full article from the original source:
View Original ArticleOpens in a new tab. Content from U.S. Department of Justice.
Notice
The summaries above are based on publicly available information released by the U.S. Department of Justice and are provided for informational purposes only. They do not constitute legal advice, investigative findings, or allegations by Disclosure Strategy. Our commentary reflects general, experience-based observations about how False Claims Act matters commonly arise and is not a statement about any party's liability.